Huber, W.
Ruiz de Garibay, A. P.
Funding for this research was provided by:
Klinikum rechts der Isar der Technischen Universität München
Article History
Received: 27 December 2019
Accepted: 14 January 2020
First Online: 24 February 2020
Compliance with ethical guidelines
:
: W. Huber is member of the Medical Advisory Board of Pulsion Medical systems SE (Getinge Group). W. Huber received speaker’s fees and travel reimbursement by ADVITOS GmbH. W. Huber is principal investigator of a clinical ECMO study supported by NovaLung/Xenios (Fresenius Medical Care). W. Huber is principal investigator of an animal study on ECMO and hemodynamics supported by Maquet GmbH (Getinge Group). A.P. Ruiz de Garibay is in an employment relationship with ADVITOS GmbH.
: For this article no studies with human participants or animals were performed by any of the authors. All studies performed were in accordance with the ethical standards indicated in each case.
: The supplement containing this article is not sponsored by industry.